Bromazepam
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01558 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 37 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | migraine disorder | KG + DL |
| 2 | migraine with brainstem aura | KG + DL |
| 3 | insomnia (disease) | KG + DL |
| 4 | migraine with or without aura, susceptibility to | KG + DL |
| 5 | atrophoderma vermiculata | KG + DL |
| 6 | anxiety | KG + DL |
| 7 | alcohol withdrawal delirium | KG + DL |
| 8 | ulerythema ophryogenesis | KG + DL |
| 9 | dysthymic disorder | KG + DL |
| 10 | tendinitis | KG + DL |
| 11 | anxiety disorder | KG + DL |
| 12 | idiopathic granulomatous myositis | KG + DL |
| 13 | myositis fibrosa | KG + DL |
| 14 | fibromyalgia | KG + DL |
| 15 | sciatic neuropathy | KG + DL |
| 16 | antidepressant type abuse | KG + DL |
| 17 | barbiturate abuse | KG + DL |
| 18 | hallucinogen abuse | KG + DL |
| 19 | neurotic disorder | KG + DL |
| 20 | benign paroxysmal torticollis of infancy | KG + DL |
| 21 | inclusion body myositis | KG + DL |
| 22 | agoraphobia | KG + DL |
| 23 | myofascial pain syndrome | KG + DL |
| 24 | sleep disorder, initiating and maintaining sleep | KG + DL |
| 25 | neurotic depression | KG + DL |
| 26 | melancholia | KG + DL |
| 27 | Keppen-Lubinsky syndrome | KG + DL |
| 28 | endogenous depression | KG + DL |
| 29 | cauda equina syndrome | KG + DL |
| 30 | restless legs syndrome | KG + DL |
| 31 | headache disorder | KG + DL |
| 32 | autosomal dominant slowed nerve conduction velocity | KG + DL |
| 33 | vitamin B12-responsive methylmalonic acidemia | KG + DL |
| 34 | congenital isolated adrenocorticotropic hormone deficiency (disease) | KG + DL |
| 35 | Ohdo syndrome and variants | KG + DL |
| 36 | peripheral arterial disease | KG + DL |
| 37 | trigeminal autonomic cephalalgia | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.